These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 16538811)
41. The morality of biotech patents: differing legal obligations in Europe? Ford R Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738 [No Abstract] [Full Text] [Related]
42. US court case to define EST patentability. Lawrence S Nat Biotechnol; 2005 May; 23(5):513. PubMed ID: 15877055 [No Abstract] [Full Text] [Related]
43. Trust, patents and public perceptions: the governance of controversial biotechnology research. Caulfield T; Einsiedel E; Merz JF; Nicol D Nat Biotechnol; 2006 Nov; 24(11):1352-4. PubMed ID: 17093477 [TBL] [Abstract][Full Text] [Related]
44. Facing up to creating life: synthetic biology unfolds its wings. Spier RE Sci Eng Ethics; 2008 Sep; 14(3):299-300. PubMed ID: 18668348 [No Abstract] [Full Text] [Related]
45. The human use of humanoid beings: chimeras and patent law. Rabin S Nat Biotechnol; 2006 May; 24(5):517-9. PubMed ID: 16680130 [TBL] [Abstract][Full Text] [Related]
46. Patentability and higher life forms. Robertson JA Nat Rev Genet; 2003 Mar; 4(3):162. PubMed ID: 12632590 [No Abstract] [Full Text] [Related]
47. Toward scalable parts families for predictable design of biological circuits. Lucks JB; Qi L; Whitaker WR; Arkin AP Curr Opin Microbiol; 2008 Dec; 11(6):567-73. PubMed ID: 18983935 [TBL] [Abstract][Full Text] [Related]
48. Ethics. Do we need "synthetic bioethics"? Parens E; Johnston J; Moses J Science; 2008 Sep; 321(5895):1449. PubMed ID: 18787154 [No Abstract] [Full Text] [Related]
49. From regenerative medicine to human design: what are we really afraid of? Stock G Free Inq; 2004; 24(4):27-30. PubMed ID: 15835004 [No Abstract] [Full Text] [Related]
51. Does patenting genes change the meaning of life? Thompson RE Physician Exec; 2003; 29(3):40-2. PubMed ID: 12774726 [No Abstract] [Full Text] [Related]
52. [Biological reductionism and the medicine of the 21st century]. Sverdlov ED Patol Fiziol Eksp Ter; 2010; (3):3-23. PubMed ID: 20853617 [TBL] [Abstract][Full Text] [Related]
54. Synthetic biology: tools to design microbes for the production of chemicals and fuels. Seo SW; Yang J; Min BE; Jang S; Lim JH; Lim HG; Kim SC; Kim SY; Jeong JH; Jung GY Biotechnol Adv; 2013 Nov; 31(6):811-7. PubMed ID: 23578899 [TBL] [Abstract][Full Text] [Related]
56. Editorial: a call for ethical regulation of genetically created organisms (GCOs) beyond GMOs. Lee SY Biotechnol J; 2010 Aug; 5(8):791. PubMed ID: 20672287 [No Abstract] [Full Text] [Related]
57. Food and agricultural biotechnology: a summary and analysis of ethical concerns. Thompson PB; Hannah W Adv Biochem Eng Biotechnol; 2008; 111():229-64. PubMed ID: 18496654 [TBL] [Abstract][Full Text] [Related]
58. Gene Designer: a synthetic biology tool for constructing artificial DNA segments. Villalobos A; Ness JE; Gustafsson C; Minshull J; Govindarajan S BMC Bioinformatics; 2006 Jun; 7():285. PubMed ID: 16756672 [TBL] [Abstract][Full Text] [Related]
59. Network benchmarking: a happy marriage between systems and synthetic biology. Minty JJ; Varedi K SM; Nina Lin X Chem Biol; 2009 Mar; 16(3):239-41. PubMed ID: 19318204 [TBL] [Abstract][Full Text] [Related]